• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Does HFpEF Exist? A Comment on "The Concept of 'Heart Failure with Preserved Ejection Fraction': Time for a Critical Reappraisal" (Rev Cardiovasc Med. 2023;24(7):202).射血分数保留的心力衰竭是否存在？对《“射血分数保留的心力衰竭”概念：进行批判性重新评估的时候了》的评论（《心血管医学综述》。2023年；24(7):202）
Rev Cardiovasc Med. 2025 Jul 25;26(7):42408. doi: 10.31083/RCM42408. eCollection 2025 Jul.
2
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
3
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy.适体蛋白质组学在心衰保留射血分数生物标志物发现中的应用：PARAGON-HF 蛋白质组学子研究。
J Am Heart Assoc. 2024 Jul 2;13(13):e033544. doi: 10.1161/JAHA.123.033544. Epub 2024 Jun 21.
4
Effects of Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: Insights From CABANA.射血分数保留的心力衰竭患者行房颤消融术的效果：来自CABANA研究的见解
JACC Heart Fail. 2025 May;13(5):785-794. doi: 10.1016/j.jchf.2025.01.029. Epub 2025 Apr 16.
5
Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.射血分数保留与降低的心衰伴房颤患者卒中及血栓栓塞风险的系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):495. doi: 10.1186/s12872-024-04133-1.
6
Ejection fraction in patients with heart failure and preserved ejection fraction is greater than in healthy controls: a meta-analysis.射血分数在心力衰竭和射血分数保留的患者中大于健康对照组：一项荟萃分析。
Eur J Intern Med. 2014 Nov;25(9):831-6. doi: 10.1016/j.ejim.2014.09.017. Epub 2014 Oct 7.
7
Microvascular dysfunction in patients with heart failure with preserved ejection fraction: A meta-analysis.射血分数保留的心力衰竭患者的微血管功能障碍：一项荟萃分析。
Microcirculation. 2023 Oct;30(7):e12822. doi: 10.1111/micc.12822. Epub 2023 Jul 25.
8
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.慢性肾脏病与替尔泊肽对射血分数保留的肥胖心力衰竭患者的影响：SUMMIT试验
J Am Coll Cardiol. 2025 May 13;85(18):1721-1735. doi: 10.1016/j.jacc.2025.03.009. Epub 2025 Mar 31.
9
[Applicability of HFPEF and HFA-PEFF Scores in Chinese Patients Suffering From Heart Failure With Preserved Ejection Fraction and Heart Failure With Preserved Ejection Fraction Complicated With Atrial Fibrillation].[射血分数保留的心力衰竭及合并心房颤动的射血分数保留的心力衰竭患者中HFPEF和HFA-PEFF评分的适用性]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Apr;46(2):154-160. doi: 10.3881/j.issn.1000-503X.15826.
10
A predictive model for heart failure with preserved ejection fraction following acute myocardial infarction: the HFpEF-AMI score.急性心肌梗死后射血分数保留的心力衰竭预测模型：HFpEF-AMI评分
BMC Cardiovasc Disord. 2025 Jul 23;25(1):535. doi: 10.1186/s12872-025-04969-1.

本文引用的文献

1
A normal heart doesn't fail: rethinking HFpEF in acute settings.正常心脏不会衰竭：重新审视急性情况下的射血分数保留的心力衰竭
Intern Emerg Med. 2025 Jun 18. doi: 10.1007/s11739-025-03989-1.
2
The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical Reappraisal.“射血分数保留的心力衰竭”概念：进行批判性重新评估的时候了。
Rev Cardiovasc Med. 2023 Jul 14;24(7):202. doi: 10.31083/j.rcm2407202. eCollection 2023 Jul.
3
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.达格列净治疗射血分数轻度降低或保留的心力衰竭。
N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.
4
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
5
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
6
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-脑啡肽酶抑制剂在射血分数保留的心力衰竭中的应用。
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
7
Spironolactone for heart failure with preserved ejection fraction.螺内酯治疗射血分数保留的心力衰竭。
N Engl J Med. 2014 Apr 10;370(15):1383-92. doi: 10.1056/NEJMoa1313731.
8
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.一种新型射血分数保留心力衰竭模式：合并症通过冠状动脉微血管内皮炎症导致心肌功能障碍和重构。
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15.
9
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.坎地沙坦对慢性心力衰竭且左心室射血分数保留患者的影响：CHARM-保留试验
Lancet. 2003 Sep 6;362(9386):777-81. doi: 10.1016/S0140-6736(03)14285-7.

Does HFpEF Exist? A Comment on "The Concept of 'Heart Failure with Preserved Ejection Fraction': Time for a Critical Reappraisal" (Rev Cardiovasc Med. 2023;24(7):202).

作者信息

Bellicini Maria Giulia

机构信息

Institute of Cardiology, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25123 Brescia, Italy.

出版信息

Rev Cardiovasc Med. 2025 Jul 25;26(7):42408. doi: 10.31083/RCM42408. eCollection 2025 Jul.

DOI:10.31083/RCM42408
PMID:40776947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12326424/
Abstract
摘要